Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-001736
Filing Date
2023-02-03
Accepted
2023-02-02 19:01:44
Documents
1
Period of Report
2023-02-02

Document Format Files

Seq Description Document Type Size
1 6-K cntb_6k_20230202.htm 6-K 97749
  Complete submission text file 0000950170-23-001736.txt   98752
Mailing Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130
Business Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130 858-727-1040
Connect Biopharma Holdings Ltd (Filer) CIK: 0001835268 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40212 | Film No.: 23582986
SIC: 2834 Pharmaceutical Preparations